News
UroMems is set to enter the pivotal trial phase with its device for treating stress urinary incontinence (SUI).
Xeltis has reported positive preliminary data for its Xabg coronary artery bypass conduit (CABG) in a trial that is underway at EU sites.
Saluda Medical has announced the full US commercial launch of its EVA sensing technology intended for scanning and analysing the spinal cord.
BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software.
The medical device industry faces being pulled into a broader contest over control, sovereignty and industrial self-sufficiency.
Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...
Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.
Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.
Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies.
Viome, with Scripps Research, is set to develop and clinically validate the first RNA test for detecting precancerous colon polyps.
Researchers at the University of Queensland (UQ) have developed a new device to facilitate drug delivery into the brain safely.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results